Depreciation of AbCellera Biologics Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
AbCellera Biologics Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • AbCellera Biologics Inc. Depreciation for the quarter ending 31 Dec 2025 was $5,230,000, a 140% increase year-over-year.
  • AbCellera Biologics Inc. Depreciation for the twelve months ending 31 Dec 2025 was $18,439,000, a 47% increase year-over-year.
  • AbCellera Biologics Inc. annual Depreciation for 2025 was $18,439,000, a 47% increase from 2024.
  • AbCellera Biologics Inc. annual Depreciation for 2024 was $12,537,000, a 1.7% decline from 2023.
  • AbCellera Biologics Inc. annual Depreciation for 2023 was $12,758,000, a 42% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

AbCellera Biologics Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $18,439,000 $5,230,000 +$3,048,000 +140% 01 Oct 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $15,391,000 $4,300,000 +$500,000 +13% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $14,891,000 $4,500,000 +$1,100,000 +32% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $13,791,000 $4,409,000 +$1,254,000 +40% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $12,537,000 $2,182,000 -$1,618,000 -43% 01 Oct 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $14,155,000 $3,800,000 +$700,000 +23% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $13,455,000 $3,400,000 +$400,000 +13% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $13,055,000 $3,155,000 +$297,000 +10% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $12,758,000 $3,800,000 +$1,038,000 +38% 01 Oct 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
Q3 2023 $11,720,000 $3,100,000 +$600,000 +24% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024 2024 Q3
Q2 2023 $11,120,000 $3,000,000 +$700,000 +30% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $10,420,000 $2,858,000 +$1,467,000 +105% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $8,953,000 $2,762,000 +$1,499,000 +119% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $7,454,000 $2,500,000 +$1,300,000 +108% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $6,154,000 $2,300,000 +$1,200,000 +109% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $4,954,000 $1,391,000 +$551,000 +66% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $4,403,000 $1,263,000 +$461,000 +57% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
Q3 2021 $3,942,000 $1,200,000 +$1,200,000 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $2,742,000 $1,100,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $2,742,000 $840,000 +$425,000 +102% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $2,317,000 $802,000 01 Oct 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $1,100,000 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $415,000 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1

AbCellera Biologics Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $18,439,000 +$5,902,000 +47% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $12,537,000 -$221,000 -1.7% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $12,758,000 +$3,805,000 +42% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $8,953,000 +$4,550,000 +103% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $4,403,000 +$2,086,000 +90% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $2,317,000 +$713,000 +44% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $1,604,000 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.